37 results
8-K
EX-99.1
INLB
Item 9 Labs Corp.
16 May 22
Item 9 Labs Corp. Announces Second Quarter FY 2022 Financial Results with Revenue Growth of 9% to $6.6 Million
12:00am
high-quality, alternative medicine to consumers nationwide. As large equity holders, our goals remain aligned with our shareholders in creating long
DEF 14C
xfcli7rr9wf59
3 Feb 21
Information statement
5:16pm
PRER14C
r6bsw
25 Jan 21
Preliminary revised information
12:00am
PRER14C
j7nwgfp g5
23 Dec 20
Preliminary revised information
6:05am
PRER14C
6wvjfqxj
21 Apr 20
Preliminary revised information
12:13pm
10-12G/A
d9qwaym2
22 Aug 19
Registration of securities (amended)
2:49pm
10-12G
ect7uvx
27 Jun 19
Registration of securities
12:00am
10-12G
EX-4.1
l6256
27 Jun 19
Registration of securities
12:00am